CSTL financials
Castle Biosciences (CSTL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CSTL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $344.23M | $273.20M | -$42.81M | -$24.16M | -0.83 |
| 2024 | $332.07M | $271.86M | $8.67M | $18.25M | 0.62 |
| 2023 | $219.79M | $174.81M | -$67.98M | -$57.47M | -2.14 |
| 2022 | $137.04M | $105.03M | -$72.86M | -$67.14M | -2.58 |
| 2021 | $94.08M | $78.26M | -$40.08M | -$31.29M | -1.24 |
| 2020 | $62.65M | $52.96M | -$6.54M | -$10.28M | -0.54 |
- CSTL revenue was $344.23M in fiscal 2025, net income -$24.16M.
Updated 2026-11-02 19:54 UTC